OVIT

OncoVista Innovative Therapies, Inc. OVIT

OVIT
OncoVista Innovative Therapies, Inc. RGMP
Regnum Corp. COTQF
Cotinga Pharmaceuticals Inc. FORU
ForU Holdings, Inc. ANTH
Anthera Pharmaceuticals, Inc. NTII
Neurobiological Technologies, Inc. LPTI
Longport, Inc. NEWG
Greenwind Holdings Inc. SYVC
Synovics Pharmaceuticals, Inc. PAOG
PAO Group, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode OVIT RGMP COTQF FORU ANTH NTII LPTI NEWG SYVC PAOG
6M 100.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 59 900.00 %
YTD 0.00 % 0.00 % 0.00 % 0.00 % -50.00 % 0.00 % 0.00 % 0.00 % 0.00 % 100.00 %
1Y 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 0.00 % 200.00 %
3Y 0.00 % -99.93 % 900.00 % 0.00 % 0.00 % 0.00 % 0.00 % 9 900.00 % 0.00 % 100.00 %
5Y -99.25 % -99.98 % -95.35 % -99.85 % -99.43 % -93.33 % -95.59 % 9 900.00 % 0.00 % -71.43 %
10Y -99.88 % -99.93 % -99.96 % -98.17 % -100.00 % -99.53 % -97.92 % 9 900.00 % 0.00 % -73.91 %
Depuis le début -99.99 % -99.93 % -99.98 % -100.00 % -100.00 % -100.00 % -99.00 % 9 900.00 % 0.00 % -97.00 %

Dividende

Neurobiological Technologies, Inc.

Longport, Inc.